Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 5
2021 3
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Monoclonal antibodies in frontline acute lymphoblastic leukemia.
Chew S, Jammal N, Kantarjian H, Jabbour E. Chew S, et al. Among authors: jammal n. Best Pract Res Clin Haematol. 2020 Dec;33(4):101226. doi: 10.1016/j.beha.2020.101226. Epub 2020 Nov 18. Best Pract Res Clin Haematol. 2020. PMID: 33279178 Review.
Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia.
Rausch CR, DiNardo CD, Maiti A, Jammal NJ, Kadia TM, Marx KR, Borthakur G, Savoy JM, Pemmaraju N, DiPippo AJ, Daver NG, Chew SM, Sasaki K, Issa GC, Short NJ, Takahashi K, Ohanian MN, Ning J, Xiao L, Alvarado Y, Kontoyiannis DP, Ravandi F, Kantarjian HM, Konopleva MY. Rausch CR, et al. Among authors: jammal nj. Cancer. 2021 Jul 15;127(14):2489-2499. doi: 10.1002/cncr.33508. Epub 2021 Apr 1. Cancer. 2021. PMID: 33793970 Free PMC article.
Antibody based therapy in relapsed acute lymphoblastic leukemia.
Jammal N, Chew S, Jabbour E, Kantarjian H. Jammal N, et al. Best Pract Res Clin Haematol. 2020 Dec;33(4):101225. doi: 10.1016/j.beha.2020.101225. Epub 2020 Nov 18. Best Pract Res Clin Haematol. 2020. PMID: 33279181 Review.
Blinatumomab is associated with favorable outcomes in patients with B-cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10-4 and higher.
Jabbour EJ, Short NJ, Jain N, Jammal N, Jorgensen J, Wang S, Wang X, Ohanian M, Alvarado Y, Kadia T, Sasaki K, Garris R, Garcia-Manero G, Ravandi F, Kantarjian HM. Jabbour EJ, et al. Among authors: jammal n. Am J Hematol. 2022 Sep;97(9):1135-1141. doi: 10.1002/ajh.26634. Epub 2022 Jun 24. Am J Hematol. 2022. PMID: 35713551 Free article. Clinical Trial.
Real-life incidence of thrombotic events in leukemia patients treated with ponatinib.
Nichols ED, Jabbour E, Jammal N, Chew S, Bryan J, Issa G, Garcia-Manero G, Sasaki K, DiPippo A, Kantarjian H. Nichols ED, et al. Among authors: jammal n. Am J Hematol. 2022 Sep;97(9):E350-E352. doi: 10.1002/ajh.26645. Epub 2022 Jul 12. Am J Hematol. 2022. PMID: 35759571 Free article. No abstract available.
Phase 2 study of lenalidomide maintenance for patients with high-risk acute myeloid leukemia in remission.
Abou Dalle I, Kantarjian HM, Ravandi F, Daver N, Wang X, Jabbour E, Estrov Z, DiNardo CD, Pemmaraju N, Ferrajoli A, Jain N, Wang SA, Jammal N, Borthakur G, Naqvi K, Pelletier S, Pierce S, Andreeff M, Garcia-Manero G, Cortes JE, Kadia TM. Abou Dalle I, et al. Among authors: jammal n. Cancer. 2021 Jun 1;127(11):1894-1900. doi: 10.1002/cncr.33409. Epub 2021 Jan 15. Cancer. 2021. PMID: 33449377 Free article. Clinical Trial.
14 results